Plasma tissue factor pathway inhibitor in disseminated intravascular coagulation: comparison of its behavior with plasma tissue factor

By Takahashi H.   Sato N.   Shibata A.  

Thrombosis Research, Vol. 80, Iss. 4, 1995-11 ,pp. : 339-348

Elsevier

Access to resources Recommend Favorite

Activity and Antigen Levels of Thrombin-Activatable Fibrinolysis Inhibitor in Plasma of Patients With Disseminated Intravascular Coagulation

By Watanabe R.   Wada H.   Watanabe Y.   Sakakura M.   Nakasaki T.   Mori Y.   Nishikawa M.   Gabazza E.C.   Nobori T.   Shiku H.  

Thrombosis Research, Vol. 104, Iss. 1, 2001-10 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

The Effect of Danaparoid Sodium (Danaparoid) on Endotoxin-induced Experimental Disseminated Intravascular Coagulation (DIC) in Rats - effects on the activation of plasminogen

By Fujishima Y.   Yokota K.   Sukamoto T.  

Thrombosis Research, Vol. 91, Iss. 5, 1998-09 ,pp. : 221-227

Elsevier

Access to resources Recommend Favorite

Protein C Inhibitor as an Anti-Disseminated Intravascular Coagulation Agent - Mechanism and Modification

By  

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 2, Iss. 1, 2004-01 ,pp. : 21-27

Bentham Science Publishers

Access to resources Recommend Favorite

Sepsis and Disseminated Intravascular Coagulation

By Levi Marcel   de Jonge Evert   van der Poll Tom  

Journal of Thrombosis and Thrombolysis, Vol. 16, Iss. 1-2, 2003-08 ,pp. : 43-47

Springer Publishing Company

Access to resources Recommend Favorite